Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma
Farah Ramadan(Université Claude Bernard Lyon 1), Sandra E. Ghayad(Inserm), Ludovic Gomez(Université Claude Bernard Lyon 1), Rita Khoueiry(Centre international de recherche sur le cancer), Zdenko Herceg(Centre international de recherche sur le cancer), Pascale A. Cohen(Lyon 1 Université), Raya Saab(Children's Health Council), Bassam Badran(Lebanese University), Farah Ghamloush(American University of Beirut Medical Center), Nader Hussein(Lebanese University), Philippe Clézardin(Université Claude Bernard Lyon 1)
Cited by 3
Related Papers
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302
Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors
|Cancer Research|2008|257